ESTEMIQ Trademark

Trademark Overview

On Friday, September 13, 2013, a trademark application was filed for ESTEMIQ with the United States Patent and Trademark Office. The USPTO has given the ESTEMIQ trademark a serial number of 86063908. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Friday, December 2, 2016. This trademark is owned by Wyeth LLC. The ESTEMIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
estemiq

General Information

Serial Number86063908
Word MarkESTEMIQ
Filing DateFriday, September 13, 2013
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateFriday, December 2, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
Translation of Words in MarkThe wording "ESTEMIQ" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateFriday, December 2, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameWyeth LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10017
Party NameWyeth LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMadison, NJ 07940

Trademark Events

Event DateEvent Description
Friday, December 2, 2016ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Friday, December 2, 2016ABANDONMENT - AFTER PUBLICATION
Thursday, December 1, 2016TEAS EXPRESS ABANDONMENT RECEIVED
Wednesday, July 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 19, 2016EXTENSION 5 GRANTED
Thursday, June 30, 2016EXTENSION 5 FILED
Thursday, June 30, 2016TEAS EXTENSION RECEIVED
Friday, January 29, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 28, 2016EXTENSION 4 GRANTED
Monday, January 11, 2016EXTENSION 4 FILED
Monday, January 11, 2016TEAS EXTENSION RECEIVED
Tuesday, August 4, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 3, 2015EXTENSION 3 GRANTED
Friday, July 17, 2015EXTENSION 3 FILED
Friday, July 17, 2015TEAS EXTENSION RECEIVED
Wednesday, March 11, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 10, 2015EXTENSION 2 GRANTED
Tuesday, January 20, 2015EXTENSION 2 FILED
Monday, March 9, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 20, 2015TEAS EXTENSION RECEIVED
Tuesday, July 15, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 11, 2014EXTENSION 1 GRANTED
Friday, July 11, 2014EXTENSION 1 FILED
Friday, July 11, 2014TEAS EXTENSION RECEIVED
Tuesday, January 28, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 6, 2014APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 6, 2014TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 3, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 3, 2013PUBLISHED FOR OPPOSITION
Wednesday, November 13, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 29, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, October 24, 2013ASSIGNED TO LIE
Tuesday, October 8, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 7, 2013EXAMINER'S AMENDMENT ENTERED
Monday, October 7, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 7, 2013EXAMINERS AMENDMENT E-MAILED
Monday, October 7, 2013EXAMINERS AMENDMENT -WRITTEN
Wednesday, October 2, 2013ASSIGNED TO EXAMINER
Friday, September 20, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 17, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

estemiq preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases